Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
No symptoms reported; RN reported that GARSASIL 9 was administered to a 47-year-old patient.; This Spontaneous report was received from a Registered Nurse and referred to a 47-year-old patient of unknown gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 07-Jan-2026, the patient started therapy with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant Suspension for injection (GARDASIL 9) injection (0.50 mL; strength, route, lot # and expiration date were not reported) for prophylaxis (Product administered to patient of inappropriate age). No symptoms reported. Lot # is being requested and will be submitted if received.